Showing results (1-10 of 651) with videos related to
Sort By:
Pageof 66
Seminars in Nuclear Medicine|July 1, 1976
Adverse reactions to radiopharmaceuticalsJ Shani, H L Atkins, W WolfInternational Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Criteria for the selection of the most desirable radionuclide for radiolabeling monoclonal antibodiesW Wolf, J ShaniInternational Journal of Nuclear Medicine and Biology|January 1, 1984
Radioiodinated prolactin as a potential mammary tumor localizing agentJ Shani, J Z Scott, D Young, et al.International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Compartmental biodistribution of a monoclonal antibody against human lung adenocarcinoma grown in athymic miceJ Shani, S Mohd, W Wolf, et al.Cancer Investigation|March 4, 2000
Enhancement of 5-fluorouracil anabolism by methotrexate and trimetrexate in two rat solid tumor models, Walker 256 carcinosarcoma and Novikoff hepatoma, as evaluated by 19F-magnetic resonance spectroscopyI Katzir, J Shani, W Wolf, et al.International Journal of Nuclear Medicine and Biology|January 1, 1985
Standardization of CDI-mediated DTPA-coupling to IgG and IgG2a antibodies for 113mIn labelingW Chanachai, J Shani, W Wolf, et al.International Journal of Nuclear Medicine and Biology|January 1, 1985
Comparative radiopharmacokinetics of 18F-5-fluorouracil administered i.v. to rats bearing a mammary tumorJ Shani, R C Manaka, D Young, et al.Nuklearmedizin. Nuclear Medicine|February 1, 1982
Metabolic and distribution studies with radiolabeled 5-fluorouracilD Young, E Vine, A Ghanbarpour, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|March 31, 1998
Overview of nuclides for bone pain palliationH L AtkinsPageof 66